| Literature DB >> 33898873 |
Xin Zhang1, Ying Li1, Zhijie Ma1, Dan He1, Haiyan Li1,2.
Abstract
More and more studies have recognized that tEntities:
Keywords: Bioglass; Hydrogels degradation; Sodium alginate; Tissue infiltration; Wound healing
Year: 2021 PMID: 33898873 PMCID: PMC8056275 DOI: 10.1016/j.bioactmat.2021.03.038
Source DB: PubMed Journal: Bioact Mater ISSN: 2452-199X
Compositions of hydrogels and corresponding label.
| Quality of sodium alginate | Quality of deferoxamine | Integration pattern | Label |
|---|---|---|---|
| 1g | 10 mg | Chemical grafting | G-DFO-1%SA/BG |
| 1g | 50 mg | Chemical grafting | G-DFO-5%SA/BG |
| 1g | 250 mg | Chemical grafting | G-DFO-25%SA/BG |
| 1g | 50 mg | Physical encapsulation | F-DFO-SA/BG |
Fig. 1Characterization of grafted SA and component optimization of hydrogels. (a) 1HNMR of SA, G-1%DFO-SA, SA, G-5%DFO-SA and SA, G-25%DFO-SA. (b) and (c) Effects of hydrogels extracts on proliferation of HDF cells and HUVECs, respectively. (d) Effects of different hydrogel extracts on in vitro vascularization of HUVECs cultured on Matrigel. (e) and (f) Quantitative analysis of meshes and junctions formed in the in vitro vascularization assay by HUVECs cultured on Matrigel with control culture medium or different hydrogel extracts, respectively. (g) Release curves of DFO from F-DFO-SA/BG and G-DFO-SA/BG hydrogels. All data are compared with Control. * represents p < 0.05, ** represents p < 0.01 and *** represents p < 0.001.
Fig. 2Characterization and degradation of SA/BG hydrogel, F-DFO-SA/BG hydrogel, and G-DFO-SA/BG hydrogel. (a) Macroscopic photographs of as-obtained hydrogels (day 0) and the hydrogels during degradation on day 3, day 5, day 7, day 10, day 14. (b) Representative images of interior structure of as-obtained hydrogels (day 0) and the hydrogels during degradation on day 3, day 5, day 10, day 14. (c) Quantitative analysis of mass change of hydrogels with degradation time. (d) Statistics of mean pore size measured from the representative SEM images. NP means not porous.
Fig. 3Characterization and degradation of SA/BG hydrogel, F-DFO-SA/BG hydrogel, and G-DFO-SA/BG hydrogel. (a) Stress-strain curve of hydrogels before (solid lines) and after (dotted lines) immersing in the PBS for 5 days. (b) Elastic modulus of as-obtained SA/BG, F-DFO-SA/BG, and G-DFO-SA/BG hydrogels. (c) Elastic modulus of SA/BG, F-DFO-SA/BG, and G-DFO-SA/BG hydrogels after immersing in the PBS for 5 days. (e) Cumulative release of Ca2+ from different hydrogels.
Fig. 4Effects of BG and DFO on cell migration in vitro. (a) Transwell migration. (b) Statistics of the number of migrated HDF cells. (c) Statistics of the number of migrated HUVECs. All data are compared with Control. * represents p < 0.05, ** represents p < 0.01 and *** represents p < 0.001.
Fig. 5Degradation of hydrogels and tissue infiltration evaluation in vivo. Representative HE stained images of SA/BG hydrogel, F-DFO-SA/BG hydrogel, and G-DFO-SA/BG hydrogel and surrounding tissues after being implanted in subcutaneous for 3 days (a), 7 days (b), 14 days (c), 21 days (d). T referrers to tissue; H referrers to hydrogel. Dash lines represent the boundary between hydrogel and tissue.
Fig. 6In vivo assessment of hydrogels for wound healing. (a) Representative gross observation images of wounds treated with nothing (Control), SA/BG hydrogel (SA/BG), F-DFO-SA/BG hydrogel (F-DFO-SA/BG) and G-DFO-SA/BG hydrogel (G-DFO-SA/BG). (b) Schematic diagram of wounds treated with different materials. Blue area: the wound area at day 0; yellow area: the remained wound area at day 7; green area: the remained wound area at day 10; red area: the remained wound area at day14. (c) Quantitative analysis of wound closure rate at day 7, day 10, day 14. (d) HE stained images of wound tissue at day 14. (e) and (f) show the representative images of Masson trichrome stained wound tissue at day 14 taken at a low and high magnification, respectively. All data are compared with Control. * represents p < 0.05, ** represents p < 0.01 and *** represents p < 0.001.
Fig. 7Vascularization in the wounds treated with nothing (Control) or different hydrogels at day 7. (a) Representative immunofluorescence images of CD31 (green), α-SMA (red) and DAPI (blue) stained tissue samples. (b) Quantitative analysis of CD 31 positive blood vessels in all wounds. (c) Quantitative analysis of α-SMA positive blood vessels in all wounds. All data are compared with Control. * represents p < 0.05, ** represents p < 0.01 and *** represents p < 0.001.
Fig. 8Immunohistochemistry analysis of VEGF and Hif-1α in wounds at day 7. (a) Represent images of immunohistochemistry staining of VEGF and Hif-1α. Quantitative analysis of VEGF positive area ratio (b) and Hif-1α positive area ratio (c). All data are compared with Control. * represents p < 0.05, ** represents p < 0.01 and *** represents p < 0.001.